Cita APA

Ordóñez García, J. L., Amaral, A. T., Montero Carcaboso, Á., Herrero Martín, D., García Macías, M. d. C., Alonso López, D., . . . Álava, E. d. (2015). The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin.

Citación estilo Chicago

Ordóñez García, José Luis, et al. The PARP Inhibitor Olaparib Enhances the Sensitivity of Ewing Sarcoma to Trabectedin. 2015.

Cita MLA

Ordóñez García, José Luis, et al. The PARP Inhibitor Olaparib Enhances the Sensitivity of Ewing Sarcoma to Trabectedin. 2015.